Biotest AG (BIO3.DE) XETRA

28.40

-1(-3.40%)

Updated at June 06 05:10PM

Currency In EUR

Valuation

Market Cap1.07B
Enterprise Value1.56B
P/E Ratio-45.1
PEG Ratio0.23
Price/Sales Ratio2.2
Price/Book Ratio2.08
Enterprise/Revenue2.97
Enterprise/EBITDA261.98

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterDecember 31, 2024

Profitability

Profit Margin-0.04
Operating Margin0.03

Management Effectiveness

Return On Assets-0.02
Return On Equity-0.05

Income Statement

Revenue726.2M
Revenue/Share16.33
Gross Profit223.8M
EBITDA120.4M
Net Income26.4M
Diluted EPS0.71

Balance Sheet

Total Cash119.5M
Total Cash/Share3.07
Total Debt597.2M
Total Debt/Equity1.13
Current Ratio5.06
Book Value Per Share13.64

Price History

52-Week Change1.07
52-Week High31.8
52-Week Low24.6
Moving Average 50 Days29.96
Moving Average 200 Days28.23

Statistics

Average Volume6,020
Shares Outstanding49.19M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.14
Payout Ratio0
Last Split Factor3:1
Last Split DateJuly 15, 2015